The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
THE IL-4 RECEPTOR: Signaling Mechanisms and Biologic Functions
Abstract
Interleukin-4 is a multifunctional cytokine that plays a critical role in the regulation of immune responses. Its effects depend upon binding to and signaling through a receptor complex consisting of the IL-4R alpha chain and the common gamma chain (gamma c), resulting in a series of phosphorylation events mediated by receptor-associated kinases. In turn, these cause the recruitment of mediators of cell growth, of resistance to apoptosis, and of gene activation and differentiation. Here we describe our current understanding of the organization of the IL-4 receptor, of the signaling pathways that are induced as a result of receptor occupancy, and of the various mechanisms through which receptor function is modulated. We particularly emphasize the modular nature of the receptor and the specialization of different receptor regions for distinct functions, most notably the independent regulation of cell growth and gene activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“previous studies have shown that phosphorylation of STAT6 is a key step downstream in the IL-4 cascade that leads to Arg1 expression (49–51).”
From Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [50]
Citations
Cites
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
SH2 domains recognize specific phosphopeptide sequences
Songyang, Z. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,620
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M. H., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,237
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Proteins regulating Ras and its relatives
Boguski, M. S., & McCormick, F. P. (1993) · Nature · doi:10.1038/366643a0 · Cited by 1,905
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,665
Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,629
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Cited by
Sorted by citations
Items 201–300 of 1,002
Porro, C., Cianciulli, A., Trotta, T., Lofrumento, D. D., & Panaro, M. A. (2019) · Biology · doi:10.3390/biology8030051 · Cited by 124
“IL-4 serves as an immunosuppressive cytokine that may inhibit the synthesis of several pro-inflammatory cytokines, as previously reported [24].”
ResultLee, C. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25711 · Cited by 123
Wen, F., Liu, X., Manda, W., Terasaki, Y., Kobayashi, T., Abe, S., Fang, Q., Ertl, R. F., Manouilova, L. S., & Rennard, S. I. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1455 · Cited by 123
Oppermann, S., Ylanko, J., Shi, Y., Hariharan, S., Oakes, C. C., Brauer, P. M., Zúñiga‐Pflücker, J. C., Leber, B. F., Spaner, D., & Andrews, D. W. (2016) · Blood · doi:10.1182/blood-2015-12-687814 · Cited by 122
“To confirm these results, IL4 was used as an alternative method to mimic the leukemic microenvironment.(24-27) The venetoclax dose response in 2S-stimulated cells was plotted against the dose response in IL4-stimulated cells and positive correlations were obtained for each of the single assays (Annexin V, R(2) 5 0.”
MethodEngineering the IL ‐4/ IL ‐13 axis for targeted immune modulation
Bernstein, Z. J., Shenoy, A., Chen, A. Y.-C., Heller, N. M., & Spangler, J. B. (2023) · Immunological Reviews · doi:10.1111/imr.13230 · Cited by 127
“3,39,125 In lymphocytes, IL-4 polarizes CD4 + T cells towards the Th2 phenotype following antigen stimulation, prompting the cells to produce type 2 cytokines (including IL-4 and IL-13), while also strongly suppressing differentiation into interferon γ (IFN γ )- producing Th1 cells.”
BackgroundInfluentialMacrophages and fibroblasts during inflammation, tissue damage and organ injury
Glaros, T. (2009) · Frontiers in bioscience · doi:10.2741/3506 · Cited by 123
Woytschak, J., Keller, N., Krieg, C., Impellizzieri, D., Thompson, R. W., Wynn, T. A., Zinkernagel, A. S., & Boyman, O. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.025 · Cited by 128
“Heter- 174 Immunity 45, 172–184, July 19, 2016 odimerization of IL-4Ra (also termed CD124) with the common g-chain (gc, also known as CD132) forms the type 1 IL-4R, which is expressed typically by hematopoietic cells, including B and T cells (LaPorte et al., 2008; Nelms et al., 1999).”
BackgroundTGF-β and IL-13 Synergistically Increase Eotaxin-1 Production in Human Airway Fibroblasts
Wenzel, S. E., Trudeau, J. B., Barnes, S., Zhou, X., Cundall, M. J., Westcott, J. Y., McCord, K. W., & Chu, H. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4613 · Cited by 121
“Because IL-13 (and IL-4) can signal through an IL-4/IL-13R complex/STAT-6 pathway and eotaxin-1 has been described to have a STAT-6 response element in its promoter, the activation of the STAT-6 pathway was evaluated (19, 20).”
BackgroundConventional, Naive CD4+ T Cells Provide an Initial Source of IL-4 During Th2 Differentiation
Noben-Trauth, N., Hu‐Li, J., & Paul, W. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3620 · Cited by 121
IL-4 induces IL-13–independent allergic airway inflammation
Perkins, C. L., Wills-Karp, M. A., & Finkelman, F. D. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.06.004 · Cited by 119
Stat6 dependent goblet cell hyperplasia during intestinal nematode infection
Khan, W. I., Blennerhassett, P. A., Ma, C., Matthaei, K. I., & Collins, S. M. (2001) · Parasite Immunology · doi:10.1046/j.1365-3024.2001.00353.x · Cited by 118
“The interaction between each cytokine and its receptor leads to activation of signalling molecules including signal transducer and activator of transcription (Stat) proteins (Nelms et al. 1999).”
BackgroundMa, S., Liu, M., Xu, Z., Li, Y., Guo, H., Ge, Y., Liu, Y., Zheng, D., & Shi, J. (2015) · Oncotarget · doi:10.18632/oncotarget.6284 · Cited by 117
“Western blot assay was performed as described previously [49].”
Wu, L. J., Martin, T. D., Vazeux, R., Unutmaz, D., & KewalRamani, V. N. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.5905-5914.2002 · Cited by 117
“Of interest, IL-4 and IL-13 signals activate the STAT-6 transcription factor, whereas cytokines that do not induce DC-SIGN do not activate STAT-6 (23) Thus, it will be interesting to examine whether STAT-6 or transcription factors induced by STAT-6, such as GATA3 (28), participate in the induction of DC-SIGN transcrip…”
BackgroundTao, B., Jin, W., Xu, J., Liang, Z., Yao, J., Zhang, Y., Wang, K., Cheng, H., Zhang, X. Z., & Ke, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303463 · Cited by 115
“These receptors recruit and activate members of the JAK tyrosine kinase family, which phosphorylate the cytoplasmic domains of receptors, creating docking sites for the STAT proteins (1, 15).”
BackgroundSugiyama, A., Sayaka, H. A. T. A., Suzuki, K., Yoshida, E., NAKANO, R., Mitra, S., Arashida, R., Asayama, Y., Yabuta, Y., & Takeuchi, T. (2010) · Journal of Veterinary Medical Science · doi:10.1292/jvms.09-0526 · Cited by 116
“IL-4-induced STAT6 activated results in transcriptional events including IgE class switching [26, 46].”
BackgroundSustained signaling by canonical helper T cell cytokines throughout the reactive lymph node
Perona‐Wright, G., Mohrs, K., & Mohrs, M. (2010) · Nature Immunology · doi:10.1038/ni.1866 · Cited by 114
IL-2 and Related Cytokines Can Promote T Cell Survival by Activating AKT
Kelly, E., Won, A., Refaeli, Y., & Parijs, L. V. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.597 · Cited by 115
“Mutations in the IL-2 or IL-4 receptors that abrogate AKT activation also prevent these cytokines from inducing a survival signal (32, 33, 38), indicating that AKT may be a critical component of the IL-2 family cytokine survival signal.”
BackgroundRegulation of Th2 Cell Differentiation by mel-18, a Mammalian Polycomb Group Gene
Kimura, M. Y., Koseki, Y., Yamashita, M., Watanabe, N., Shimizu, C., Katsumoto, T., Kitamura, T., Taniguchi, M., Koseki, H., & Nakayama, T. (2001) · Immunity · doi:10.1016/s1074-7613(01)00182-0 · Cited by 115
Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis
Li, Z., Jiang, J., Wang, Z., Zhang, J., Xiao, M., Wang, C., Yu, L., & Qin, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0449 · Cited by 114
“Endogenous IL-4 is primarily produced by various host immune cells, including T cells, mast cells, basophils, and sometimes NKT cells, gy T cells ( 37 ).”
Oeser, K., Schwartz, C., & Voehringer, D. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.101 · Cited by 113
von Känel, R., Bellingrath, S., & Kudielka, B. M. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.02.007 · Cited by 122
David, M. D., Ford, D., Bertoglio, J. H., Maizel, A., & Pierre, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204629 · Cited by 113
“We have previously described that in the A431 keratinocyte cell line, IL-4 not only activated the JAK/ STAT pathway, but also regulated the activity of various members of the MAPK family, in contrast to what has been described in most hematopoietic cells (Nelms et al., 1999).”
BackgroundResultSanson, M., Distel, E., & Fisher, E. A. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074676 · Cited by 116
“The classical pathway for IL-4-induced polarization involves the activation of the STAT6 (Signal Transducer and Activator of Transcription) signaling pathway [22] and STAT6 is one of the trans factors that bind to the promoter of Arg-1 and Fizz-1 [17,23].”
BackgroundLi, J., Shao, J.-Z., Xiang, L., & Wen, Y. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.010 · Cited by 110
Rudge, E. U., Cutler, A. J., Pritchard, N. R., & Smith, K. G. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011435 · Cited by 112
“This amplifying effect could account for the IL-4–dependent production of very large amounts of IgG1 and IgE seen in Th2 responses, and in particular in allergy and in chronic parasitic infections (15).”
BackgroundIL-4: an important cytokine in determining the fate of T cells
Silva‐Filho, J. L., Caruso‐Neves, C., & Pinheiro, A. A. S. (2014) · Biophysical Reviews · doi:10.1007/s12551-013-0133-z · Cited by 111
“kinase activity; instead, they require receptor-associated kinases, referred to as the Janus family (Jak) tyrosine kinases, which are critical in the initiation of signaling pathways (Paul 1991; Takeda et al. 1996; Nelms et al. 1999).”
InfluentialTIM Family of Genes in Immunity and Tolerance
Kuchroo, V. K., Meyers, J. H., Umetsu, D. T., & DeKruyff, R. H. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)91006-2 · Cited by 111
Spanbroek, R., Hildner, M., Köhler, A., Müller, A., Zintl, F., Kühn, H., Rådmark, O., Samuelsson, B. O., & Habenicht, A. J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091076998 · Cited by 111
Wu, C.-T., Chen, P.-J., Lee, Y.-T., Ko, J., & Lue, K.-H. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.08.001 · Cited by 110
Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases
Zhou, Y., Zhang, Y., Han, J., Yang, M., Zhu, J., & Jin, T. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02289-w · Cited by 110
“IL‐4 IL-4 is a multifunctional cytokine that promotes mature B cell activation and induces B cell differentiation, proliferation, and antibody secretion by acting as a cofactor for lipopolysaccharides, CD40L, and antigen stimulation [77, 78].”
Macrophages Orchestrate Airway Inflammation, Remodeling, and Resolution in Asthma
Britt, R. D., Ruwanpathirana, A., Ford, M. L., & Lewis, B. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310451 · Cited by 116
“Eosinophils release granules containing IL-4 and IL-10 that further enhance type 2 immune responses commonly associated with asthma [57].”
BackgroundVälineva, T., Yang, J., Palovuori, R., & Silvennoinen, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410465200 · Cited by 111
Epithelial interleukin-4 receptor expression promotes colon tumor growth
Koller, F. L., Hwang, D. G., Dozier, E. A., & Fingleton, B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq044 · Cited by 110
Suzuki, K., Nakajima, H., Watanabe, N., Kagami, S., Suto, A., Saito, Y., Saito, T., & Iwamoto, I. (2000) · Blood · doi:10.1182/blood.v96.6.2172 · Cited by 109
Zheng, C., Yang, Q., Xu, C., Shou, P., Cao, J., Jiang, M., Chen, Q., Cao, G., Han, Y., Li, F., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500396113 · Cited by 115
“Interestingly, IL-4Rα possesses an ITIM domain on the C terminal that has been reported to recruit SHP-1, which in turn down-regulates the IL-4–initiated signaling process (58).”
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines
Dwyer, C. J., Knochelmann, H. M., Smith, A. S., Wyatt, M. M., Rivera, G. O. R., Arhontoulis, D. C., Bartee, E., Li, Z., Rubinstein, M. P., & Paulos, C. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00263 · Cited by 107
Interleukin-4/STAT6 Represses STAT1 and NF-κB-dependent Transcription through Distinct Mechanisms
Ohmori, Y., & Hamilton, T. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006227200 · Cited by 106
Cho, S. H., Ahn, A., Bhargava, P., Lee, C., Eischen, C. M., McGuinness, O. P., & Boothby, M. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017082108 · Cited by 113
“IL-4, which collaborates with B-cell receptor cross-linking to enhance proliferation (5, 6, 15, 24), increased the glycolytic response to anti-IgM in WT, but not PARP14- or Stat6-null, B cells (Fig.”
BackgroundInfluentialInsights into the Pathogenesis of Asthma Utilizing Murine Models
Taube, C., Dakhama, A., & Gelfand, E. W. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000080899 · Cited by 109
Lorentz, A., Wilke, M., Sellge, G., Worthmann, H., Klempnauer, J. L., Manns, M. P., & Bischoff, S. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6751 · Cited by 106
Genetic Contributions to Disparities in Preterm Birth
Anum, E. A., Springel, E. H., Shriver, M. D., & Strauss, J. F. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31818912e7 · Cited by 107
Identification of Novel IL-4/Stat6-Regulated Genes in T Lymphocytes
Chen, Z. J., Lund, R., Aittokallio, T. A., Kosonen, M., Nevalainen, O., & Lahesmaa, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3627 · Cited by 107
“All Stats have similar DNA binding motifs, which are called IFN- -activated sequences (4, 5).”
BackgroundXu, Z., Pone, E. J., Al-Qahtani, A. A., Park, S., Zan, H., & Casali, P. (2007) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v27.i4.60 · Cited by 108
Cho, S. H., Goenka, S., Henttinen, T. A., Gudapati, P., Reinikainen, A., Eischen, C. M., Lahesmaa, R., & Boothby, M. R. (2009) · Blood · doi:10.1182/blood-2008-03-144121 · Cited by 114
“(B) Equal masses of protein in extracts from normal B cells or carefully excised primary tumor masses from 4 separate mice (1-4) were analyzed by Western blotting as described in panel A.”
MethodNon-coding RNA-based regulation of inflammation
Ashrafizadeh, M., Zarrabi, A., Mostafavi, E., Aref, A. R., Sethi, G., Wang, L., & Tergaonkar, V. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101606 · Cited by 107
Interleukin-4 Stimulates Proliferation of Endometriotic Stromal Cells
Ouyang, Z., Hirota, Y., Osuga, Y., Hamasaki, K., Hasegawa, A., Tajima, T., Hirata, T., Koga, K., Yoshino, O., Harada, M., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071044 · Cited by 105
Li, L., Liu, D., Hutt‐Fletcher, L. M., Morgan, A. J., Masucci, M. G., & Levitsky, V. (2002) · Blood · doi:10.1182/blood.v99.10.3725 · Cited by 105
Cytokine receptor signalling and aging
Fülöp, T., Larbi, A., Douziech, N., Levesque, I., Varin, A., & Herbein, G. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.025 · Cited by 104
Aberrant Stat3 Signaling by Interleukin-4 in Malignant Glioma Cells: Involvement of IL-13Rα2
Rahaman, S. O., Vogelbaum, M. A., & Haque, S. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3592 · Cited by 104
“Although IL-4 induces the differentiation and growth of B and T lymphocytes ( 10 , 11), it inhibits the proliferation of astrocytes that are derived from nonneoplastic cortex or lowgrade gliomas but not from high-grade gliomas (12–14).”
BackgroundMethodInfluentialYamashita, M., Katsumata, M., Iwashima, M., Kimura, M. Y., Shimizu, C., Kamata, T., Shin, T., Seki, N., Suzuki, S., Taniguchi, M., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1869 · Cited by 105
“The enhanced STAT6 and IRS-2 phosphorylation may be the result of the increased activation of Jak1 and Jak3, as well as increased protein levels of STAT6 and IRS-2.”
InfluentialGut motor function: immunological control in enteric infection and inflammation
Khan, W. I., & Collins, S. M. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02979.x · Cited by 103
Zhu, L., Pan, P., Fang, W., Shao, J.-Z., & Xiang, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102259 · Cited by 102
“In this process, IL-4 stimulates the proliferation of mast cells with IL-13 and promotes Ig class switching to IgE that binds to high-affinity Fcε receptors on the surfaces of mast cells, basophils, and eosinophils, leading to the degranulation and production of inflammatory mediators when it is cross-linked by an Ag…”
BackgroundGene expression profiles in rat lung after inhalation exposure to C60 fullerene particles
Fujita, K., Morimoto, Y., Ogami, A., Myojyo, T., Tanaka, I., Shimada, M., Wang, W., Endoh, S., Uchida, K., Nakazato, T., et al. (2009) · Toxicology · doi:10.1016/j.tox.2009.01.005 · Cited by 101
Geba, G. P., Li, D., Xu, M., Mohammadi, K. A., Attre, R., Ardeleanu, M., & Musser, B. J. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.08.026 · Cited by 101
Redox Regulation of Interleukin-4 Signaling
Sharma, P., Chakraborty, R., Wang, L., Min, B., Tremblay, M. L., Kawahara, T., Lambeth, J. D., & Haque, S. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.019 · Cited by 103
“Interleukin (IL)-4 is an immunomudulatory, type I cytokine secreted by activated Th2lymphocytes, basophils and mast cells (Haque and Sharma, 2006; Nelms et al., 1999).”
BackgroundMethodInfluentialIntegrin???Interleukin-4 Mechanotransduction Pathways in Human Chondrocytes
Salter, D. M., Millward-Sadler, S. J., Nuki, G., & Wright, M. O. (2001) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200110001-00006 · Cited by 100
Volkmann, L., Bain, O., Saeftel, M., Specht, S., Fischer, K., Brombacher, F., Matthaei, K. I., & Hoerauf, A. (2003) · Medical Microbiology and Immunology · doi:10.1007/s00430-002-0155-9 · Cited by 99
“[11,30] In an infection system with Schistosoma mansoni protective immune responses were not dependent on IL-4 when IL-4 deficient C57BL/6 mice were used [14,18] but on IL-13, as shown in BALB/c IL-4R a chain KO [29].”
MethodInterleukin-8 favors pro-inflammatory activity of human monocytes/macrophages
Meniailo, M. E., Malashchenko, V. V., Шмаров, В. А., Газатова, Н. Д., Melashchenko, O. B., Goncharov, A. G., Seledtsova, G. V., & Seledtsov, V. I. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.036 · Cited by 99
IL-4 Receptor Signaling in Clara Cells Is Required for Allergen-Induced Mucus Production
Kuperman, D. A., Huang, X., Nguyenvu, L. T., Hölscher, C., Brombacher, F., & Erle, D. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3746 · Cited by 99
“IL-4R signaling in both T cells and B cells is critical for IgE production (18).”
BackgroundCytokines and inflammation in adipogenesis: an updated review
Jiang, N., Yao, L., Shu, T., & Wang, J. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0625-0 · Cited by 104
NFIL3/E4BP4 controls type 2 T helper cell cytokine expression
Kashiwada, M., Cassel, S. L., Colgan, J. D., & Rothman, P. B. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.111 · Cited by 98
“Furthermore, IL-4 upregulates MHC class II on B cells and IgE receptors on inflammatory cells, resulting in the enhancement of antigen presenting ability to T cells and IgE-mediated secretion of inflammatory mediators, respec- tively (Nelms et al, 1999).”
BackgroundUl‐Haq, Z., Naz, S., & Mesaik, M. A. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.04.002 · Cited by 98
“cells, and eosinophils, beside Th2 lymphocytes [1].”
BackgroundInfluentialAnti-Inflammatory Activity of Inhaled IL-4 Receptor-α Antisense Oligonucleotide in Mice
Karras, J. G., Crosby, J. R., Guha, M., Tung, D., Miller, D. A., Gaarde, W. A., Geary, R. S., Monia, B. P., & Gregory, S. A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0456oc · Cited by 95
“As a common signaling chain of both the IL-4 and IL-13 receptors, IL-4R functions as a key intermediary protein in Th2 cytokine responses ( 7 ).”
BackgroundCytokines and Cytokine Receptors
O’Shea, J. J., Gadina, M., & Siegel, R. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00009-0 · Cited by 104
Gao, Z., Chen, J., Qiu, S., Li, Y., Wang, D., Liu, C., Li, X., Hou, R., Yue, C., Liu, J., et al. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.09.065 · Cited by 96
Integration of cytokine and heterologous receptor signaling pathways
Bezbradica, J. S., & Medzhitov, R. M. (2009) · Nature Immunology · doi:10.1038/ni.1713 · Cited by 97
“In T cells, for example, phosphorylated IL-4R recruits STAT6, but also PTB-containing IRS-1, IRS-2, Shc and perhaps other, yet to be identified protein”
BackgroundHong, H.-Y., Lee, H. Y., Kwak, W., Yoo, J., Na, M., So, I. S., Kwon, T., Park, H., Huh, S., Oh, G. T., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00189.x · Cited by 96
“Type I receptor is present in haematopoietic cells, while type II receptor is in haematopoietic cells of the myeloid lineage, such as macrophages and eosinophils, and in many other cell types, such as endothelial cells and fibroblasts [17, 18].”
BackgroundFoxa2 Programs Th2 Cell-Mediated Innate Immunity in the Developing Lung
Chen, G., Wan, H., Luo, F., Zhang, L., Xu, Y. J., Lewkowich, I. P., Wills-Karp, M. A., & Whitsett, J. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000223 · Cited by 96
Targeting IL4/IL4R for the treatment of epithelial cancer metastasis
Venmar, K. T., & Fingleton, B. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9747-9 · Cited by 95
“In normal tissues, the primary binding chain for IL4, IL4 receptor a (IL4Ra) [10, 14], is expressed on T and B lymphocytes, eosinophils, macrophages, endothelial cells, lung fibroblasts, bronchial epithelial cells, MDSCs, and smooth muscle cells [11, 15–20].”
InfluentialNappo, G., Handle, F., Santer, F. R., McNeill, R. V., Seed, R., Collins, A. T., Morrone, G., Čulig, Z., Maitland, N. J., & Erb, H. H. H. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.23 · Cited by 95
“The activated genes include AKT, p44/42 MAPK, NF-kB, and the JAK/STAT6 pathways, which represents the main mediator of IL-4 signalling in immune cells (19).”
InfluentialCytokine memory of T helper lymphocytes
Löhning, M., Richter, A., & Radbruch, A. (2002) · Advances in immunology · doi:10.1016/s0065-2776(02)80014-1 · Cited by 96
Aoudjehane, L., Pissaia, A., Scatton, O., Podevin, P., Massault, P. P., Chouzenoux, S., Soubrane, O., Calmus, Y., & Conti, F. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.61 · Cited by 99
“IL-4 exerts its effects by binding to and stimulating its transmembrane receptor (IL-4R), involving the Janus kinases (JAK)-1 and JAK-3, and the signal transducer and activator of transcription (STAT)-6 pathway.(25) In vitro studies have shown that IL-4 can induce fibrosis by activating lung fibroblast proliferation,…”
BackgroundSteinke, J. W. (2004) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2004.06.008 · Cited by 95
“The phosphorylation of the IL-4Ra cytoplasmic region also provides a docking site for the insulin receptor substrate 1 (IRS-1) and its homolog IRS-2 [33].”
BackgroundCostimulation, Coinhibition and Cancer
Inman, B. A., Frigola, X., Dong, H., & Kwon, E. D. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006878 · Cited by 97
“Interleukin 4 (IL-4) is involved in the differentiation of TH cells into specific subsets, in particular the TH2 subset [81].”
BackgroundSchröder, A., Pavlidis, P., Arimura, A., Capece, D., & Rothman, P. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.996 · Cited by 96
Scheinman, E. J., & Avni, O. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807302200 · Cited by 93
Livraghi-Butrico, A., Grubb, B. R., Hudson, E. J., Wilkinson, K. J., Sheehan, J. K., Mall, M. A., O’Neal, W. K., Boucher, R. C., & Randell, S. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802557 · Cited by 91
“IL-4Rα is a shared component of the receptors for IL-4 and IL-13, two cytokines that trigger Th2-type airway inflammation and remodeling (15,16) and have been highly implicated in the pathogenesis of allergy and asthma (17,18).”
BackgroundGATA-3 transcriptional imprinting in Th2 lymphocytes: A mathematical model
Höfer, T., Nathansen, H., Löhning, M., Radbruch, A., & Heinrich, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142284699 · Cited by 90
Analysis of γc-Family Cytokine Target Genes
Kovanen, P. E., Rosenwald, A., Fu, J., Hurt, E. M., Lam, L. T., Giltnane, J. M., Wright, G. W., Staudt, L. M., & Leonard, W. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209015200 · Cited by 90
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis
Haddad, E., Cyr, S. L., Arima, K., McDonald, R. A., Levit, N. A., & Nestle, F. O. (2022) · Dermatology and Therapy · doi:10.1007/s13555-022-00737-7 · Cited by 94
“IL-13 binds to IL-13Ra1 and recruits IL-4Ra, forming the type II receptor [39, 88].”
BackgroundThe Role of Interleukin 13 in Classical Hodgkin Lymphoma
Skinnider, B., Kapp, U., & Mak, T. W. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290026259 · Cited by 88
“Signal transduction through the Type II IL-4R occurs primarily via the IL-4Ra chain [25].”
BackgroundRegulation of Chemokine Expression by Antiinflammatory Cytokines
Hamilton, T. A., Ohmori, Y., & Tebo, J. M. (2002) · Immunologic Research · doi:10.1385/ir:25:3:229 · Cited by 92
Moderate exercise may attenuate some aspects of immunosenescence
Drela, N., Kozdroń, E., & Szczypiorski, P. (2004) · BMC Geriatrics · doi:10.1186/1471-2318-4-8 · Cited by 89
“IL-2, IL-4 and IFN-γ are multifunctional cytokines involved in the development and effectors functions regulation of T, B and NK cells [26-28].”
BackgroundWurster, A. L., Withers, D. J., Uchida, T., White, M. F., & Grusby, M. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.117-126.2002 · Cited by 88
“Deletion and mutagenesis studies of the human IL-4R chain in transfected cell lines has led to the functional categorization of the phosphotyrosine residues in the IL-4R chain cytoplasmic tail (24).”
BackgroundWurtz, O. (2004) · International Immunology · doi:10.1093/intimm/dxh050 · Cited by 90
“Alternatively, partial inhibition may reflect a proliferative or survival defect of STAT6-deficient Th1 cells when deprived of IL-12 ( 26 ).”
BackgroundWen, F., Kohyama, T., Liu, X., Zhu, Y. K., Wang, H., Kim, H. J., Kobayashi, T., Abe, S., Spurzem, J. R., & Rennard, S. I. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.4.4784 · Cited by 89
“Both IL-4 and IL-13 interact with specific receptors which are capable of activating several signal transduction pathways leading to altered gene expression (38).”
BackgroundFaffe, D. S., Whitehead, T. R., Moore, P. E., Baraldo, S., Flynt, L., Bourgeois, K., Panettieri, R. A., & Shore, S. A. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00120.2003 · Cited by 89
“The I4R motif of the IL-4R is also required for insulin receptor substrate binding and subsequent ERK phosphorylation (29).”
Cytokines and Chemokines in HBV Infection
Zhong, S., Zhang, T., Tang, L., & Li, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.805625 · Cited by 90
“Interleukin-4 IL-4 is distinguished as a T helper (Th)2 cytokine that tilts the adaptive response toward humoral immunity by motivating proliferation, differentiation, and antibodies production of B cells, promoting Th2 cells differentiation from naïve CD4 T cells and inhibiting Th1 responses as well as IFN-γ producti…”
BackgroundMacrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics
Peng, M., Li, N., Wang, H., Li, Y., Liu, H., Luo, Y., Lang, B., Zhang, W., Li, S., Tian, L., et al. (2025) · MedComm · doi:10.1002/mco2.70304 · Cited by 98
“…Type I receptors, which bind only IL-4 and are composed of IL-4R α and γ c subunits (the latter also acts as a subunit in IL-2, IL-7, IL-9, IL-15, and IL-21 receptor complexes); and Type II receptors, which can bind both IL-4 and IL-13 and are composed of IL-4R α and IL-13R α 1 subunits [125, 126].”
Opportunistic Infection-Associated Immune Reconstitution Syndrome in Transplant Recipients
Sun, H., & Singh, N. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir276 · Cited by 88
“Th2 cells secrete mainly interleukin (IL)-4 and IL-10, leading to anti-inflammatory and immunosuppressive responses [4, 5].”
Omori, M., Yamashita, M., Inami, M., Ukai‐Tadenuma, M., Kimura, M. Y., Nigo, Y., Hosokawa, H., Hasegawa, A., Taniguchi, M., & Nakayama, T. (2003) · Immunity · doi:10.1016/s1074-7613(03)00210-3 · Cited by 87
IL‐4 induces expression of TARC/CCL17 via two STAT6 binding sites
Wirnsberger, G., Hebenstreit, D., Posselt, G., Horejs‐Hoeck, J., & Duschl, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200635972 · Cited by 89
Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease
Foster, P. S., Martinez-Moczygemba, M., Huston, D. P., & Corry, D. B. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00220-6 · Cited by 87
Venmar, K. T., Carter, K. J., Hwang, D. G., Dozier, E. A., & Fingleton, B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0093 · Cited by 86
“Activated Akt [9] and Stat6 [5, 10, 11] are known regulators of proliferation and survival.”
BackgroundResultInfluentialIFN-γ and IFN-α Posttranscriptionally Down-Regulate the IL-4-Induced IL-4 Receptor Gene Expression
So, E. Y., Park, H.-H., & Lee, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5472 · Cited by 86
“IL-4-responsive element (IL-4RE) (11) sequence (FceRIIb IFN-g-activated site (GAS) (12): 59-GGGTGAATTTCTAAGAAAGGG-39) was labeled using [a-32P]dCTP and Klenow, and the binding reaction with the nuclear extract was performed in the buffer containing 10 mM Tris-Cl (pH 7.5), 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, 1 mM EDTA,…”
BackgroundMethodInfluentialBandeira‐Melo, C., Woods, L. J., Phoofolo, M., & Weller, P. F. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020516 · Cited by 86
“The actions of IL-4 are not limited to the initiation of Th2 responses, but may also stimulate other cellular responses that contribute to manifestations of allergic diseases (12, 13).”
BackgroundCytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections
Li, X., Liu, X., Tian, L., & Chen, Y. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8465-4 · Cited by 104
Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines
Junttila, I., Creusot, R. J., Moraga, I., Bates, D. L., Wong, M. T., Alonso, M. N., Suhoski, M. M., Lupardus, P. J., Meier‐Schellersheim, M., Engleman, E. G., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1096 · Cited by 85
Lee, C., & Choi, E. Y. (2018) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2018.25.1.11 · Cited by 92
Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer
Shi, J., Song, X., Traub, B., Luxenhofer, M., & Kornmann, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062998 · Cited by 85
“The multiple functions of IL-4 are ini iated through the binding of IL-4 to its respective transfer membrane receptor chain (Figure 2), IL-4-receptor (IL-4R), in both the type I receptor complex, comprising of IL-4-receptor alpha (IL-4Rα) and the co on g mma chain (γc) (IL-4/IL-4Rα/γc) [41], predominantly expressed on…”
BackgroundInfluential
Metadata
- Authors
- Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Nelms, Keats
- Paul, William E.
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 1999-04
- Volume
- 17
- Issue
- 1
- Pages
- 701-738
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2144120552
- Cited by
- 1,545
- References
- 190
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 52 · 2023: 36 · 2022: 54 · 2021: 43 · 2020: 50 · 2019: 44 · 2018: 54 · 2017: 49 · 2016: 52 · 2015: 56 · 2014: 72 · 2013: 52 · 2012: 55
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- IL-4, IL-4 receptor, common gamma chain, receptor signaling, receptor phosphorylation, cell growth regulation, apoptosis resistance, gene activation, T cell differentiation, cytokine signaling
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Phosphoproteins, Signal Transduction, Trans-Activators, Interleukin-4, Protein Tyrosine Phosphatases, Calcium-Calmodulin-Dependent Protein Kinases, Mice, Knockout, Receptors, Interleukin-4, Mitogen-Activated Protein Kinases, Intracellular Signaling Peptides and Proteins, JNK Mitogen-Activated Protein Kinases, STAT6 Transcription Factor, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review